ASX - Delayed Quote AUD

CD Private Equity Fund III (CD3.AX)

1.1450
0.0000
(0.00%)
At close: May 16 at 10:02:01 AM GMT+10
Loading Chart for CD3.AX
  • Previous Close 1.1450
  • Open 1.1450
  • Bid 1.2100 x --
  • Ask 1.2750 x --
  • Day's Range 1.1450 - 1.1450
  • 52 Week Range 1.1000 - 1.4850
  • Volume 1,795
  • Avg. Volume 19,633
  • Market Cap (intraday) 82.473M
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date May 28, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jan 29, 2025
  • 1y Target Est --

CD Private Equity Fund III specializes in investments in small and specialised private equity funds targeting lower middle-market operating businesses in the United States.

www.cdfunds.com.au/fund3/

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CD3.AX

View More

Performance Overview: CD3.AX

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

CD3.AX
0.61%
S&P/ASX 200 [XJO] (^AXJO)
2.26%

1-Year Return

CD3.AX
8.44%
S&P/ASX 200 [XJO] (^AXJO)
5.87%

3-Year Return

CD3.AX
62.90%
S&P/ASX 200 [XJO] (^AXJO)
17.63%

5-Year Return

CD3.AX
377.55%
S&P/ASX 200 [XJO] (^AXJO)
54.38%

Compare To: CD3.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CD3.AX

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    82.47M

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.66

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -1.70%

  • Return on Equity (ttm)

    -2.83%

  • Revenue (ttm)

    -2.84M

  • Net Income Avi to Common (ttm)

    -3.83M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -5.1M

Research Analysis: CD3.AX

View More

People Also Watch